Lataa...
Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
Globally, the death rate of pancreatic ductal adenocarcinoma (PDAC) has doubled over 30 years and is likely to further increase, making PDAC a leading cause of cancer-related death in the coming years. PDAC is typically diagnosed at an advanced stage, and modified FOLFIRINOX or nab-paclitaxel and ge...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409054/ https://ncbi.nlm.nih.gov/pubmed/32708493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12071955 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|